pharma Β· Patency of the Ductus Arteriosus Β· Atopic Dermatitis Β· CNTB
S.L
S.L patent portfolio β 179 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, EU
- Programs
- 15
- Drugs
- 11
- Patents
- 179
S.L patents
179 pharmaceutical patents indexed for S.L. 16 expire within 24 months.
S.L has 179 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 16 expire within 24 months β use filters for patent-cliff planning.
Patent portfolio
-
US 7241799
Cannabimimetic indole derivatives
granted -
US 7186115
Advanced thermoplastics for orthodontics
granted -
US 7183313
Keto cannabinoids with therapeutic indications
granted -
US 7179462
Ξ± (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
granted -
US 7173027
Receptor selective cannabimimetic aminoalkylindoles
granted -
US 7135324
Viral recombinases, related articles, and methods of use thereof
granted -
US 7132109
Using heat shock proteins to increase immune response
granted -
US 7118873
Polynucleotides encoding cellular transporters and methods of use thereof
granted -
US 7118752
Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I
granted -
US 7087723
Albumin-free factor VIII formulations
granted -
US 7057076
Bicyclic and tricyclic cannabinoids
granted -
US 6995187
Peripheral cannabinoid receptor (CB2) selective ligands
expired -
US 6995299
Propagation of human hepatocytes in non-human animals
expired -
US 6984389
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
expired -
US 6962904
Elastin peptide analogs and uses thereof
expired -
US 6900236
Cannabimimetic indole derivatives
expired -
US 6809075
Elastin peptide analogs and uses of same incombination with skin enhancing agents
expired -
US 6794362
Asparagine containing elastin peptide analogs
expired -
US 6777389
Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
expired -
US 6749847
Hybrid cytokine of IL-7 and &bgr;-chain of hepatocyte growth factor
expired -
US 6716607
Chicken interferon gene and novel recombinant DNA
expired -
US 6713772
Free-form fabrication using multi-photon excitation
expired -
US 6692910
Inhibition of a target messenger RNA with a modified U1 small nuclear RNA
expired -
US 6610302
Anti-tumor activity of Ea-2 and Ea-4-peptide of pro-IGF-I
expired -
US 6586573
Albumin-free Factor VIII formulations
expired -
US 6579900
Anandamide amidase inhibitors as analgesic agents
expired -
US 6525242
Propagation of human hepatocytes in non-human mammals
expired -
US 6506731
Elastin peptide analogs and methods of using same
expired -
US 6451316
Methods for generating antigen-reactive T cells in vitro
expired -
US 6391909
Anandamide inhibitors as analgesic agents
expired -
US 6316153
Free-form fabricaton using multi-photon excitation
expired -
US 6299873
Method for improvement of radiation therapy of malignant tumors
expired -
US 6046009
Diagnosis and treatment of glaucoma
expired -
US 6030954
Targeted delivery of poly- or oligonucleotides to cells
expired -
US 6020465
Recombinant avian type i interferon
expired
Frequently asked questions
How many patents does S.L have?
179 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do S.L patents expire?
16 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.